首页 | 本学科首页   官方微博 | 高级检索  
检索        


The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level
Authors:Ryogo Minamimoto  Hiroji Uemura  Futoshi Sano  Hideyuki Terao  Yoji Nagashima  Shoji Yamanaka  Kazuya Shizukuishi  Ukihide Tateishi  Yoshinobu Kubota  Tomio Inoue
Institution:(1) Division of Nuclear Medicine, Department of Radiology, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjyuku-ku, Tokyo 162-8655, Japan;(2) Department of Radiology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan;(3) Department of Urology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan;(4) Department of Molecular Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Japan;(5) Division of Anatomic and Surgical Pathology, Yokohama City University Hospital, Yokohama, Japan
Abstract:

Purpose  

The aim of this study is to evaluate the potential and limitation of FDG-PET/CT for detecting prostate cancer in subjects with an elevated serum prostate-specific antigen (PSA) level. Although 18F]-2-fluoro-2-deoxyglucose positron emission tomography (FDG-PET) has limited value in detecting prostate cancer, the potential of PET/CT has not been precisely evaluated, since positron emission tomography/computed tomography (PET/CT) provides accurate localization of functional findings obtained by PET.
Keywords:
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号